Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 5, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc.
| 24.14K |
$53.69 | -$935,118.73 | +4.47% | 563.91K |
Mar 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -30.00K |
$45.00 | -$1,350,000.00 | -5.27% | 539.77K |
Feb 7
| |||||||
Ultragenyx Pharmaceutical Inc.
| -30.00K |
$47.87 | -$1,436,100.00 | -5.00% | 569.77K |
Dec 29
| |||||||
Ultragenyx Pharmaceutical Inc.
|
0
|
$20.19 | -$1,275,760.98 |
—
| 1.25M |
Oct 19
| |||||||
Ultragenyx Pharmaceutical Inc.
| 38.78K |
$45.65 | -$736,791.00 | +3.30% | 1.21M |
Mar 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -19.58K |
$45.57 | -$892,351.74 | -3.49% | 541.11K |
Dec 30
|
Scheduled
| ||||||
Ultragenyx Pharmaceutical Inc.
| 39.88K |
$67.37 | -$819,353.94 | +6.71% | 634.23K |
Mar 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -853.00 |
$81.00 | -$69,093.00 | -0.14% | 594.35K |
Oct 14
| |||||||
Ultragenyx Pharmaceutical Inc.
| -852.00 |
$115.71 | -$98,584.92 | -0.14% | 595.2K |
May 6
| |||||||
Ultragenyx Pharmaceutical Inc.
| -30.00K |
$107.80 | -$3,234,000.00 | -1.31% | 2.26M |
May 3
|
Scheduled
| ||||||
Ultragenyx Pharmaceutical Inc.
| -12.89K |
$142.14 | -$6,582,244.74 | -0.44% | 2.89M |
Mar 1
|
Scheduled
| ||||||
Ultragenyx Pharmaceutical Inc.
| -30.00K |
$136.90 | -$4,107,000.00 | -1.27% | 2.33M |
Jan 4
|
Scheduled
| ||||||
Ultragenyx Pharmaceutical Inc.
| -30.00K |
$96.82 | -$2,904,600.00 | -1.26% | 2.36M |
Nov 2
|
Scheduled
| ||||||
Ultragenyx Pharmaceutical Inc.
| -852.00 |
$92.69 | -$78,971.88 | -0.14% | 610.19K |
Oct 14
| |||||||
Ultragenyx Pharmaceutical Inc.
| -30.00K |
$82.63 | -$2,478,900.00 | -1.24% | 2.39M |
Sep 1
|
Scheduled
| ||||||
Ultragenyx Pharmaceutical Inc.
| -40.00K |
$85.35 | -$3,414,000.00 | -1.63% | 2.42M |
Jul 13
|
Scheduled
| ||||||
Ultragenyx Pharmaceutical Inc.
| -1.33K |
$69.38 | -$92,552.92 | -0.22% | 611.04K |
Jun 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -852.00 |
$66.26 | -$56,453.52 | -0.13% | 652.8K |
May 6
| |||||||
Ultragenyx Pharmaceutical Inc.
| -851.00 |
$58.57 | -$49,843.07 | -0.13% | 653.65K |
Apr 19
| |||||||
Ultragenyx Pharmaceutical Inc.
| 149.7K |
$3.01 | $449,998.20 | +29.66% | 654.5K |
Mar 12
| |||||||
Ultragenyx Pharmaceutical Inc.
| 28.89K |
$56.08 | -$386,727.68 | +6.07% | 504.8K |
Mar 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| 3.44K |
—
|
—
| +0.73% | 475.91K |
Oct 14
| |||||||
Ultragenyx Pharmaceutical Inc.
| 5K |
$43.63 | $218,150.00 | +1.07% | 472.48K |
Sep 11
| |||||||
Ultragenyx Pharmaceutical Inc.
| -1.33K |
$54.93 | -$72,892.11 | -0.28% | 467.48K |
Jun 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -1.41K |
$59.50 | -$84,133.00 | -0.30% | 468.81K |
May 21
| |||||||
Ultragenyx Pharmaceutical Inc.
| 3.44K |
—
|
—
| +0.74% | 470.22K |
May 6
| |||||||
Ultragenyx Pharmaceutical Inc.
| -798.00 |
$64.43 | -$51,415.14 | -0.17% | 466.79K |
Apr 19
| |||||||
Ultragenyx Pharmaceutical Inc.
| 17.11K |
$65.52 | -$189,352.80 | +3.80% | 467.58K |
Mar 1 - Mar 5
| |||||||
Ultragenyx Pharmaceutical Inc.
| 17.2K |
$67.55 | -$189,275.10 | +3.82% | 467.67K |
Mar 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -926.00 |
$73.73 | -$68,273.98 | -0.21% | 450.47K |
Jun 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -986.00 |
$64.79 | -$63,882.94 | -0.22% | 451.4K |
May 21
| |||||||
Ultragenyx Pharmaceutical Inc.
| 3.43K |
—
|
—
| +0.76% | 452.38K |
Apr 19
| |||||||
Ultragenyx Pharmaceutical Inc.
| 18.39K |
$48.43 | -$53,951.02 | +4.27% | 448.95K |
Mar 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| 7.5K |
$52.52 | $393,922.32 | +0.29% | 2.56M |
Aug 28
| |||||||
Ultragenyx Pharmaceutical Inc.
| -1.01K |
$56.61 | -$56,949.66 | -0.23% | 430.57K |
Jun 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -1.07K |
$57.47 | -$61,607.84 | -0.25% | 431.57K |
May 21
| |||||||
Ultragenyx Pharmaceutical Inc.
| 13K |
—
|
—
| +3.10% | 432.65K |
Mar 1
| |||||||
Ultragenyx Pharmaceutical Inc.
| -20.00K |
$81.29 | -$1,625,753.15 | -4.28% | 447.15K |
Nov 15
|
Scheduled
| ||||||
Ultragenyx Pharmaceutical Inc.
| -20.00K |
$63.02 | -$1,260,360.40 | -4.11% | 467.15K |
Oct 14
|
Scheduled
| ||||||
Ultragenyx Pharmaceutical Inc.
| -20.00K |
$67.61 | -$1,352,250.81 | -3.94% | 487.15K |
Aug 15
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.